About Us

Sun Yat-sen University Cancer Center (SYSUCC) was established in 1964 and is one of the four earliest tumor hospitals in China. It is one of the affiliated hospitals of the prestigious Sun Yat-sen University. Located in the city of Guangzhou, SYSUCC is leading the way on a national frontier. It is the largest integrated cancer center in China for cancer care, education, research and prevention. SYSUCC’s mission is to help people prevent and cure cancer.

SYSUCC has been awarded many prestigious titles over the years:
*  1994 Tertiary Class A Hospital
*  1999 Guangdong Provincial Key Laboratory of NPC
*   2001 National Key Disciplines (Oncology)
*   2001 National Clinical Study Center for Anticancer Drugs
*   2005 State Key Laboratory (SKL) of Oncology in South China
*   2009 Cancer Hospital of Chinese Traditional and Western Medicine
*   2011 National Key Clinical Specialty (Thoracic Surgery)
*   2011 National Key Clinical Specialty (Oncology)
*   2012 Member of the Union for International Cancer Control (UICC)
*   2018 Collaborative Innovation Center for Cancer Medicine
*   2021 National Key Clinical Specialty (Radiation Therapy)
*   2023 National Key Clinical Specialty (General Surgery)

SYSUCC is also a supporting institute for the Guangdong Cancer Center, the Guangdong Esophageal Cancer Research Institute and the Guangdong Anti-cancer Association. SYSUCC also hosts the SCI journal Cancer Communications. It has an impact factor of 16.2 in 2022, ranking in Q1 among the global Oncology Journals, and making it the top comprehensive oncology journal with the highest impact factor in Asia.

Medical care

SYSUCC currently has two operational campuses with a third pending. The first campus is located in the Yuexiu district of Guangzhou city and the second campus is in Huangpu district and a third planned in Tianhe district.

SYSUCC is a modern medical service provider with 2,247 ward beds, 42 surgery rooms and 35 clinical departments. In 2023, SYSUCC handled over 1.84 million outpatient visits, 185,408 inpatient stays, and performed 45,492 surgeries. Equipped with state of the art medical technology, the center has a premier radiation therapy center and four da Vinci robots (two at each campus) for minimally invasive surgeries. Embracing the era of "digital pathology", SYSUCC also stands among China's first two specialized cancer hospitals to adopt this cutting-edge technology. SYSUCC provides a comprehensive range of health care services for cancer diagnosis and treatment including surgery, radiotherapy, chemotherapy, interventional therapy, immunotherapy, and Traditional Chinese Medicine (TCM). 

SYSUCC never stops improving its quality of service pushing the boundaries of research and patient care. The responsibility system of the chief expert for a single cancer disease was first applied in our center and the multi-disciplinary diagnosis and treatment plan for different cancer diseases were designed by our specialists. Under the effort of the physicians-scientists and researchers at SYSUCC, 70 clinical research achievements have been adopted by international treatment guidelines since 2019, providing new treatment options for cancer patients worldwide.

SYSUCC has a comprehensive range of medical departments and centers at both campuses, unless stated otherwise:
Biotherapy Center
Blood Transfusion
Bone and Soft Tissue Surgery (Huangpu Campus only)
Breast Oncology
Cancer Prevention Research
Clinical Nutrition
Clinical Trial Center
Colorectal Surgery
Gastric Surgery
Gynecological Oncology
Head and Neck Surgery
Hematological Oncology (Huangpu Campus only)
Intensive Care Unit
Liver Surgery
Medical Imaging
Medical Oncology
Medicine Laboratory
Minimally Invasive Therapy
Molecular Diagnosis (Huangpu Campus only)
Nasopharyngeal Carcinoma
Neurosurgery (Yuexiu Campus only)
Nuclear Medicine
Pancreaticobiliary Surgery (Huangpu Campus only)
Pediatric Oncology
Radiation Oncology
Screening Center for Cancer Prevention
Thoracic Surgery
Traditional Chinese Medicine
Ultrasound and Electrocardiogram
VIP Inpatient

Sun Yat-sen University Cancer Center (SYSUCC) is one of the foremost institutions for cultivating oncology talent in China, especially in Guangdong Province. In 1964, the Ministry of Health commissioned SYSUCC to establish a national oncology clinical medicine training course, which has since trained more than 5,000 oncology professionals nationwide. Since being approved as one of the first National Standardized Residency Training Bases in 2014, SYSUCC now offers 10 National Standardized Residency Training Programs, dedicated to cultivating high-quality medical professionals in China.


As one of the earliest cancer hospitals founded in China, SYSUCC has always closely combined its clinical and research attributes. Since 2001, a tumor tissue bank has been established to provide researchers with a dynamic collection of biological samples for cancer research. To help bridge the gap between basic drug research and clinical applications, a Clinical Trial Center (CTC) was also setup to assist physicians and scientists to test new therapies. It includes a National Clinical Study Center for Anticancer Drugs. The State Key Laboratory (SKL) of Oncology in South China was founded in 2005 by the Ministry of Science and Technology in China. This laboratory is jointly operates out of the Yuexiu and Huangpu campuses. Its activities cover a broad spectrum in oncology from basic to translational and clinical research.

The center intensified its research and innovation efforts and established a high-level research platform to drive the rapid development of scientific initiatives. In 2023, SYSUCC secured 134 National Natural Science Foundation of China (NSFC) projects with total funding of RMB 80.59 million. In 2024, a total of 13 studies from SYSUCC have been selected as oral presentations in the ASCO Annual Meeting. Over the last five years, clinical studies of SYSUCC scholars have been published in top four medical journals including the LancetNew England Journal of Medicinethe BMJ and JAMA. In the Nature Index Ranking 2022, SYSUCC was ranked No. 4 globally and No. 1 in China among cancer hospitals.
International Collaboration

In 2003, SYSUCC became a sister institution of the University of Texas MD Anderson Cancer Center (MDACC) -- a top-ranking cancer research institute and hospital in the United States. Given its long lasting collaboration with SYSUCC, MDACC was awarded "the International Scientific and Technological collaboration Award" from the State Council of China in 2015. SYSUCC also has numerous international partners all around the world, including the Netherlands Cancer Institute (NKI), Karolinska Institutet, the University of Warwick, Fred Hutchinson and the Erasmus Medical Center.  SYSUCC has also been a longstanding UICC member since 2012. Together, we combine different approaches as part of the same goal in our fight to conquer cancer.

In 2023, Sun Yat-sen University Cancer Center Tianhe Campus commenced construction. To be fitted with 1,100 beds and heavy ion radiotherapy equipment, it is designed to be a world-class hub for cancer prevention, treatment, and technological innovation, substantially expanding high-quality medical resources.

Updated May 2024

Where are we | Contact us|

Copyright:Sun Yat-sen University Cancer Center Designed by Wanhu.